# LABCORP HOLDINGS INC. (LH) · Edgar & Edgarette company card

> Labcorp Holdings (LH) grew revenue 7.2% in FY2025 to $14.0 billion, operating margin 9.9% against a -12.4% median for medical laboratories, equity 46.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 920148 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/LH) · [JSON](https://www.pops4.com/boards/company/LH.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $14.0B |
| Revenue growth, 1 year | 7.2% |
| Revenue growth per year | 1.5% |
| Operating margin | 9.9% (prior year 8.4%) |
| Net margin | 6.3% |
| Operating cash flow | $1.6B |
| Capital spending | $435M |
| Free cash flow | $1.2B |
| Cash | $532M |
| Long-term debt | $5.6B |
| Total assets | $18.4B |
| Total equity | $8.6B |
| Equity ÷ assets | 46.9% |
| Return on equity | 10.2% |
| Dividend per share | $2.88 |
| Dividend years rising | 0 |

## Readings, computed from those figures

- Altman Z: 3.39 (safe zone)
- Piotroski F: 8 of 9 (strong)
- Beneish M: -2.55 (below the −1.78 line)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $14.0B (FY2025), total debt $5.6B. Experience: revenue up 7.2% on the year, up 1.5% a year over 4 years; operating margin 9.9%, up from 8.4%. Soundness: equity 46.9% of assets, return on equity 10.2%, payout 27.4% of profit. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $13.0B and $15.9B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $11.9B to $17.2B. A statistical range, not company guidance. Against peers (17 filers, $50M+ revenue, services-medical laboratories): operating margin 9.9% against a -12.4% median; growth 7.2% against 13.8%.

Range logged 2026-09-26, receipt 0c3cbd37230bf89b, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 5, latest 2026-08-14 ([filing](https://www.sec.gov/Archives/edgar/data/920148/000092014826000182/0000920148-26-000182-index.htm))

## Recent filings

- 8-K · filed 2026-11-04 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/920148/000092014826000227/0000920148-26-000227-index.htm)
- 10-Q · filed 2026-10-30 · [filing](https://www.sec.gov/Archives/edgar/data/920148/000092014826000222/0000920148-26-000222-index.htm)
- 8-K · filed 2026-10-28 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/920148/000092014826000213/0000920148-26-000213-index.htm)
- 8-K · filed 2026-10-21 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/920148/000092014826000210/0000920148-26-000210-index.htm)
- 8-K · filed 2026-09-30 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/920148/000092014826000207/0000920148-26-000207-index.htm)
- 8-K · filed 2026-09-22 · 7.01 Regulation FD Disclosure · [filing](https://www.sec.gov/Archives/edgar/data/920148/000092014826000205/0000920148-26-000205-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000920148.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=920148

## Cite

POPS4, Edgar & Edgarette: LABCORP HOLDINGS INC. (LH) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/LH. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.